Nexalin acquires PONM digital health platform for HALO Clarity for $1.3M in stock

Nexalin Technology, Inc.

Acquisition of all PONM shares for $1.3M in Nexalin common stock; first tranche of 959,016 shares issued at closing.
PONM platform, already deployed at UCSD, supports AI-integrated remote monitoring, EHR, and virtual-clinic workflows.
Planned 160-participant FDA pivotal trial for HALO Clarity in moderate-to-severe insomnia; enrollment expected Q2 2026.
GreenLight becomes a meaningful equity holder and enters strategic partnership for development, regulatory, and commercial support.
Collaboration Agreement with GLV provides ongoing development services at $10,000/month for 24-month initial term.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Nexalin Technology, Inc. entered into Stock Purchase Agreement with GreenLight Ventures LLC valued at 1,300,000 (effective 2026-05-14).

Action: entry
Agreement: equity purchase
Counterparty: GreenLight Ventures LLC
Value: 1,300,000
Effective: 2026-05-14

Exact text from the filing

On May 14, 2026, Nexalin Technology, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with GreenLight Ventures LLC, a North Carolina limited liability company (“GLV”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Nexalin Technology, Inc. entered into Collaboration Agreement with GreenLight Ventures LLC valued at 10,000 per month (effective 2026-05-14).

Action: entry
Agreement: collaboration
Counterparty: GreenLight Ventures LLC
Value: 10,000 per month
Effective: 2026-05-14

Exact text from the filing

On May 14, 2026, the Company entered into a Collaboration Agreement (the “Collaboration Agreement”) with GLV to support the development, compliance and commercialization of the Company’s cranial electrotherapy stimulation technologies and related products using certain licensed software associated with GLV’s digital technology platforms.

View on SEC.gov

Browse all material agreements →

Nexalin Technology, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-26-005453

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.